Page 112 - Read Online

Brunsing et al. Hepatoma Res 2020;6:59 I http://dx.doi.org/10.20517/2394-5079.2020.50 Page 15 of 16

acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 2015;204:527-35.
29. Besa C, Lewis S, Pandharipande PV, Chhatwal J, Kamath A, et al. Hepatocellular carcinoma detection: diagnostic performance of a
simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
Abdom Radiol 2017;42:179-90.
30. Tillman BG, Gorman JD, Hru JM, Lee MH, King MC, et al. Diagnostic per-lesion performance of a simulated gadoxetate disodium-
enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clin Radiol 2018;73:485-93.
31. Brunsing RL, Chen DH, Schlein A, Wolfson T, Gamst A, et al. Gadoxetate-enhanced abbreviated MRI for hepatocellular carcinoma
surveillance: preliminary experience. Radiol Imaging Cancer 2019;1:e190010.
32. Park SH, Kim B, Kim SY, Shim YS, Kim JH, et al. Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence
MRI: LI-RADS validation in a HCC-screening cohort. Eur Radiol 2020;30:2302-11.
33. Canellas R, Rosenkrantz AB, Taouli B, Sala E, Saini S, et al. Abbreviated MRI protocols for the abdomen. Radiographics 2019;39:744-58.
34. Sutherland T, Watts J, Ryan M, Galvin A, Temple F, et al. Diffusion-weighted MRI for hepatocellular carcinoma screening in chronic
liver disease: direct comparison with ultrasound screening. J Med Imaging Radiat Oncol 2017;61:34-9.
35. Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D
T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 2006;239:438-47.
36. McNamara MM, Thomas JV, Alexander LF, Little MD, Bolus DN, et al. Diffusion-weighted MRI as a screening tool for hepatocellular
carcinoma in cirrhotic livers: correlation with explant data-a pilot study. Abdom Radiol (NY) 2018;43:2686-92.
37. Lima PH, Fan B, Bérubé J, Cerny M, Olivié D, et al. Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular
carcinoma. AJR Am J Roentgenol 2019;17:1-9.
38. Cerny M, Bergeron C, Billiard JS, Murphy-Lavallée J, Olivié D, et al. LI-RADS for MR imaging diagnosis of hepatocellular carcinoma:
performance of major and ancillary features. Radiology 2018;288:118-28.
39. Park MS, Kim S, Patel J, Hajdu CH, Do RKG, et al. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-
enhanced magnetic resonance imaging in pretransplant patients. Hepatology 2012;56:140-8.
40. Zhang T, Huang ZX, Wei Y, Jiang HY, Chen J, et al. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement
magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? World J Gastroenterol 2019;25:622-31.
41. Basha MAA, Refaat R, Mohammad FF, Khamis MEM, El-Maghraby AM, et al. The utility of diffusion-weighted imaging in improving
the sensitivity of LI-RADS classification of small hepatic observations suspected of malignancy. Abdom Radiol 2019;44:1773-84.
42. Min JH, Kim YK, Choi SY, Jeong WK, Lee WJ, et al. Differentiation between cholangiocarcinoma and hepatocellular carcinoma with
target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: classification tree analysis
applying capsule and septum. Eur J Radiol 2017;92:1-10.
43. Park HJ, Kim YK, Park MJ, Lee WJ. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for
differentiation from hepatocellular carcinoma. Abdom Imaging 2013;38:793-801.
44. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced
T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2013;
270:834-41.
45. Choi JW, Moon WJ. Gadolinium deposition in the brain: current updates. Korean J Radiol 2019;20:134-47.
46. Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic
resonance. J Cardiovasc Magn Reson 2012;14:31.
47. Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, et al. Role of diffusion weighted imaging (DWI) for hepatocellular carcinoma (HCC)
detection and its grading on 3T MRI: a prospective study. J Clin Exp Hepatol 2016;6:303-10.
48. Chandarana H, Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol 2010;76:348-58.
49. Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, et al. Histological grade of differentiation of hepatocellular carcinoma:
comparison of the efficacy of diffusion-weighted MRI with T2-weighted imaging and angiography-assisted CT. J Med Imaging Radiat
Oncol 2012;56:261-9.
50. An C, Kim DY, Choi JY, Han KH, Roh YH, et al. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular
carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial. BMC Cancer 2018;24:18.
51. Pinho DF, Lev-Cohain N, Awdeh H, Xi Y, Khatri G, et al. Optimization of breathing instructions and timing of late arterial phase
acquisition on gadobutrol-enhanced MRI of the liver. Clinical Imaging 2016;40:1274-9.
52. Contrast Manual. American College of Radiology; 2020. Available from: https://www.acr.org/Clinical-Resources/Contrast-Manual. [Last
accessed on 13 Jul 2020]
53. Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, et al. New OPTN/UNOS policy for liver transplant allocation:
standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 2013;266:376-82.
54. Ultrasound LI-RADS v2017. American College of Radiology. Available from: https://www.acr.org/Clinical-Resources/Reporting-and-
Data-Systems/LI-RADS/Ultrasound-LI-RADS-v2017. [Last accessed on 13 Jul 2020]
55. Nassif A, Jia J, Keiser M, Oswald S, Modess C, et al. Visualization of hepatic uptake transporter function in healthy subjects by using
gadoxetic acid-enhanced MR imaging. Radiology 2012;264:741-50.
56. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-
enhanced MR imaging. Radiology 2011;261:834-44.
57. Rosenkrantz AB, Campbell N, Wehrli N, Triolo MJ, Kim S. New OPTN/UNOS classification system for nodules in cirrhotic livers
detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Radiology 2014;274:426-33.